Canopy, the first Intelligent Care Platform for oncology, today announced its commitment to CancerX, a public-private partnership co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe), alongside the Office for the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH).

CancerX was announced by U.S. President Joe Biden and Dr. Jill Biden in February 2023 as part of The White House’s reignited national Cancer Moonshot initiative. As a CancerX member, Canopy will collaborate with other leaders in the oncology and digital health space to set priorities and practices that will help harness the full power of innovation to achieve the goals of the Cancer Moonshot.

“Canopy’s mission is to provide the best possible outcomes and experience for every person with cancer. Our mission is well aligned with the objectives of CancerX, and we are eager to partner with other leading organizations in delivering the latest cancer innovations to people living with cancer and their communities.”

—Lavi Kwiatkowsky, Canopy Founder and CEO

A comprehensive platform for all the care that happens between visits, Canopy enables oncology practices to identify and prioritize patients who need help, remotely resolve issues with intelligent software, and generate new reimbursement streams from high-quality care. Canopy’s ePRO-based remote monitoring system empowers patients to seamlessly report symptoms between office visits, enabling care teams to intervene as needed.

Studies of the Canopy ePRO show high engagement (JCO, 2022) and improved outcomes for patients (ASCO 2022):

Together with fellow CancerX leaders, Canopy is committed to unleashing the power of innovation to fight cancer.

Contact the Canopy team to learn more.

1. Cherny, N. I., Parrinello, C. M., Kwiatkowsky, L., Hunnicutt, J., Beck, T., Schaefer, E., Thurow, T., & Kolodziej, M. (2022). Feasibility of Large-Scale Implementation of an Electronic Patient-Reported Outcome Remote Monitoring System for Patients on Active Treatment at a Community Cancer Center. JCO Oncology Practice, 18(12), e1918-e1926. DOI: 10.1200/OP.22.00180

2. Kolodziej, M. A., Kwiatkowsky, L., Parrinello, C., Thurow, T., Schaefer, E. S., Beck, J. T., Cherny, N., & Blau, S. (2022). ePRO-based digital symptom monitoring in a community oncology practice to reduce emergency room and inpatient utilization. Journal of Clinical Oncology, 40(16_suppl), 1508.

Authors observed a 22 percent lower rate of adverse clinical events, specifically emergency room and hospital admission.

3. Parrinello, C., Calkins, G., Kwiatkowsky, L., Schaefer, E. S., Beck, J. T., Ellis, A. R., Blau, S., Telivala, B. P., & Kolodziej, M. A. (2022). Time on treatment is prolonged in patients utilizing an ePRO based digital symptom monitoring platform in the community setting. Journal of Clinical Oncology, 40(16_suppl), 1528. DOI: 10.1200/JCO.2022.40.16_suppl.1528